Overview

A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Generalized Pustular Psoriasis

Status:
Completed

Trial end date:
2021-01-20

Target enrollment:

Participant gender:

Summary

An open label study investigating the efficacy and safety, and pharmacokinetic (PK) profile of ANB019 in subjects with generalized pustular psoriasis

Phase:

Phase 2

Details

Lead Sponsor:

AnaptysBio, Inc.